Quadria Capital-backed Concord Biotech Pvt pivots to IPO, appoints banker

By Ranjani Raghavan

  • 10 Sep 2021
Premium
Credit: VCCircle

Quadria Capital-backed Concord Biotech has appointed a merchant bank as it moves a step forward towards raising capital via a public issue and helping its investor secure an exit, two persons close to the deal told VCCircle.   The Ahmedabad-based biopharmaceuticals business has appointed Kotak Mahindra Capital for an IPO. Quadria ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.